This article is more than 5 years old. Information may no longer be current.

Stellaris Elite receives 510(k) clearance

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has granted 510(k) clearance to the Stellaris Elite phacoemulsification platform, according to a Bausch + Lomb press release.

Stellaris Elite is the first vision enhancement system available with Adaptive Fluidics, combining aspiration control with predictive infusion management, the release said. It also allows surgeons to customize their machines and features the Attune energy management system, which allows it to “deliver efficient, low energy controlled emulsification.”

“We know that our customers are looking for a surgical system that will deliver responsiveness and maximum control throughout every moment of the procedure while having the latest technology machine very cost effectively, and that’s exactly what we’ve designed Stellaris Elite to do,” Chuck Hess, Bausch + Lomb vice president and general manager, U.S. Surgical, said in the release.

The company plans to launch the product for retina uses this summer, integrating retina and cataract capabilities in one machine.